Malchair P, Giol J, Garcia V, Rodriguez O, et al. Three-day icatibant on top of standard care in patients with COVID-19 pneumonia (ICAT.COVID): a randomized, open-label, phase 2, proof-of-concept trial. Clin Infect Dis 2023 Jan 4:ciac984. doi: 10.1093.
PMID: 36610464